ALLMedicine™ Mechanical Ventilation Center
Research & Reviews 17,379 results
https://doi.org/10.1016/j.nmd.2020.12.002
Neuromuscular Disorders : NMD; Vidanagamage A, Gooneratne IK et. al.
Jan 25th, 2021 - Congenital myasthenic syndromes (CMS) are genetically determined heterogenous disorders of neuromuscular transmission. We report a rare mutation of COLQ causing CMS in an Asian man that remarkably improved with fluoxetine. A 51-year-old Sri Lankan...
https://doi.org/10.1053/j.jvca.2020.12.028
Journal of Cardiothoracic and Vascular Anesthesia; Gazda AJ, Kwak MJ et. al.
Jan 25th, 2021 - Early tracheostomy (fewer than eight days after intubation) is associated with shorter length of stay in the intensive care unit and shorter duration of mechanical ventilation. Studies assessing the association between early tracheostomy and incid...
https://doi.org/10.1016/j.clnesp.2020.10.018
Clinical Nutrition ESPEN; Otaka S, Aso S et. al.
Jan 25th, 2021 - Parenteral nutrition in the early phase is often performed for patients with trauma who have undergone laparotomy. However, the clinical benefits of parenteral nutrition in the early phase in this population remain unknown. We investigated the ass...
https://doi.org/10.1016/j.clnesp.2020.11.026
Clinical Nutrition ESPEN; Mousavi MA, Saghaleini SH et. al.
Jan 25th, 2021 - Patients hospitalized at the intensive care unit (ICU) are more prone to oxidative stress. Antioxidants such as selenium (Se) may have beneficial effects on outcomes in these patients. Studies and systematic reviews in this field have inconclusive...
https://doi.org/10.1007/s00705-021-04956-9 10.1056/NEJMoa2001017 10.1111/resp.13196 10.7326/M20-1334 10.7326/M20-2496 10.1002/cpt.1844 10.1136/bmjopen-2020-039730 10.1073/pnas.1811345115 10.1177/2472555220942123 10.1080/07391102.2020.1761882 10.2174/1871526520666200520112848 10.1007/s12072-020-10072-8 10.2174/1871526520666200726224802 10.2174/1871530320999201117142305 10.1016/j.ijid.2020.03.071 10.1016/j.jhep.2020.09.024 10.1016/j.eng.2020.03.007 10.3758/BF03193146 10.1016/j.antiviral.2014.02.014 10.1016/j.antiviral.2015.08.015 10.4269/ajtmh.20-0290 10.1128/AAC.49.3.981-986.2005 10.1186/s13054-020-03078-z
Archives of Virology; Dabbous HM, Abd-Elsalam S et. al.
Jan 25th, 2021 - No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized controlled study including 96 patients with COVID- 1...
Guidelines 67 results
https://doi.org/10.1159/000510085
Respiration; International Review of Thoracic Diseases; Schönhofer B, Geiseler J et. al.
Dec 10th, 2020 - Mechanical ventilation (MV) is an essential part of modern intensive care medicine. MV is performed in patients with severe respiratory failure caused by respiratory muscle insufficiency and/or lung parenchymal disease; that is, when other treatme...
https://doi.org/10.1159/000510086
Respiration; International Review of Thoracic Diseases; Janssens JP, Michel F et. al.
Dec 10th, 2020 - Long-term mechanical ventilation is a well-established treatment for chronic hypercapnic respiratory failure (CHRF). It is aimed at improving CHRF-related symptoms, health-related quality of life, survival, and decreasing hospital admissions. In S...
https://doi.org/10.1089/sur.2020.101
Surgical Infections; Heffernan DS, Evans HL et. al.
Apr 20th, 2020 - Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-associated viral infection (coronavirus disease 2019, COVID-19) is a virulent, contagious viral pandemic that is affecting populations worldwide. As with any airborne viral r...
http://www.cmaj.ca/content/191/37/E1018
CMAJ
Sep 15th, 2019 - BACKGROUND: Donepezil, rivastigmine and galantamine are popular cholinesterase inhibitors used to manage the symptoms of Alzheimer disease and other dementias; regulatory agencies in several countries warn about a possible risk of rhabdomyolysis w...
https://doi.org/10.1159/000502157
Respiration; International Review of Thoracic Diseases; Fichtner F, Moerer O et. al.
Sep 10th, 2019 - For patients with acute respiratory insufficiency, mechanical ("invasive") ventilation is a fundamental therapeutic measure to ensure sufficient gas exchange. Despite decades of strong research efforts, central questions on mechanical ventilation ...
Drugs 219 results see all →
Clinicaltrials.gov 18,227 results
https://doi.org/10.1016/j.nmd.2020.12.002
Neuromuscular Disorders : NMD; Vidanagamage A, Gooneratne IK et. al.
Jan 25th, 2021 - Congenital myasthenic syndromes (CMS) are genetically determined heterogenous disorders of neuromuscular transmission. We report a rare mutation of COLQ causing CMS in an Asian man that remarkably improved with fluoxetine. A 51-year-old Sri Lankan...
https://doi.org/10.1053/j.jvca.2020.12.028
Journal of Cardiothoracic and Vascular Anesthesia; Gazda AJ, Kwak MJ et. al.
Jan 25th, 2021 - Early tracheostomy (fewer than eight days after intubation) is associated with shorter length of stay in the intensive care unit and shorter duration of mechanical ventilation. Studies assessing the association between early tracheostomy and incid...
https://doi.org/10.1016/j.clnesp.2020.10.018
Clinical Nutrition ESPEN; Otaka S, Aso S et. al.
Jan 25th, 2021 - Parenteral nutrition in the early phase is often performed for patients with trauma who have undergone laparotomy. However, the clinical benefits of parenteral nutrition in the early phase in this population remain unknown. We investigated the ass...
https://doi.org/10.1016/j.clnesp.2020.11.026
Clinical Nutrition ESPEN; Mousavi MA, Saghaleini SH et. al.
Jan 25th, 2021 - Patients hospitalized at the intensive care unit (ICU) are more prone to oxidative stress. Antioxidants such as selenium (Se) may have beneficial effects on outcomes in these patients. Studies and systematic reviews in this field have inconclusive...
https://doi.org/10.1007/s00705-021-04956-9 10.1056/NEJMoa2001017 10.1111/resp.13196 10.7326/M20-1334 10.7326/M20-2496 10.1002/cpt.1844 10.1136/bmjopen-2020-039730 10.1073/pnas.1811345115 10.1177/2472555220942123 10.1080/07391102.2020.1761882 10.2174/1871526520666200520112848 10.1007/s12072-020-10072-8 10.2174/1871526520666200726224802 10.2174/1871530320999201117142305 10.1016/j.ijid.2020.03.071 10.1016/j.jhep.2020.09.024 10.1016/j.eng.2020.03.007 10.3758/BF03193146 10.1016/j.antiviral.2014.02.014 10.1016/j.antiviral.2015.08.015 10.4269/ajtmh.20-0290 10.1128/AAC.49.3.981-986.2005 10.1186/s13054-020-03078-z
Archives of Virology; Dabbous HM, Abd-Elsalam S et. al.
Jan 25th, 2021 - No specific antiviral drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter randomized controlled study including 96 patients with COVID- 1...
News 767 results
https://www.medscape.com/viewarticle/944541
Jan 24th, 2021 - NIEDERBREITBACH, Germany (Reuters) - Since the outbreak of the coronavirus pandemic, chronically ill 30-year-old Benni Over has lived in strict domestic quarantine in the German resort town of Niederbreitbach with his parents, who look after him a...
https://www.medscape.com/viewarticle/943238
Dec 28th, 2020 - (Reuters) - Low vitamin D levels are linked with higher risk for severe COVID-19, but treatment that boosted vitamin D levels in critically ill COVID-19 patients did not shorten their hospital stay or lower their odds of intensive care unit admiss...
https://www.medscape.com/viewarticle/942882
Dec 17th, 2020 - (Reuters Health) - The interleukin-6 inhibitor tocilizumab reduced the combined likelihood of mechanical ventilation or death by 44% among mostly non-white patients hospitalized with COVID-19, according to a new international randomized test of 38...
https://www.medscape.com/viewarticle/942811
Dec 16th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Among US veterans hospitalized with COVID-19, about one third experienced acute kidney injury (AKI) during the pandemic's first wave, but there wa...
https://www.medscape.com/viewarticle/942573
Dec 14th, 2020 - ZURICH (Reuters) - Novartis said a late-stage clinical trial of ruxolitinib on top of standard therapy showed no significant reduction in severe complications of COVID-19, including death, respiratory failure requiring mechanical ventilation or ad...